Thenappan Thenappan is a Cardiology physician affiliated with University of Minnesota. OpenAlex indexes 304 publications with 9,394 citations (h-index 45); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
909 Fulton St SE
Minneapolis, MN 554554800
Telephone
612-672-7422Provider last certified this registry record 17 Jun 2025.
Clinical trials
1 registered study on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20251 payment
- Medtronic, Inc.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20245 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
59.6%Endothelin Receptor Antagonist16.3%Opsumit79%Ambrisentan21%Part D<11 patientsLoop diuretic10.2%Furosemide59%Torsemide22%Bumetanide19%Part D≥69 patients+ 13 more classes in this area
Genitourinary & hormones
13.8%Phosphodiesterase 5 Inhibitor13.8%Sildenafil Citrate55%Tadalafil45%Part D≥47 patientsBlood & clotting
13.1%Prostacycline Vasodilator6.3%Tyvaso Dpi100%Part D≥28 patientsProstacyclin Receptor Agonist2.7%Uptravi100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results
European Respiratory Journal
2024 - Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective
American Journal of Respiratory and Critical Care Medicine
2024 - Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
European Respiratory Journal
2023 - Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
Journal of the American Heart Association
2022 - Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites
American Journal of Respiratory and Critical Care Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Blazar, MD
University of Minnesota
Jay Cohn, MD
University of Minnesota
Julia Steinberger, MD
University of Minnesota
Charles Herzog, MD
University of Minnesota
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”